1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Petra Acquisition, Inc.

Petra Acquisition, Inc.

PAICU
Petra Acquisition, Inc.US flagNASDAQ Global Select
10.75
USD
-0.41
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
CEO
Andreas A. Typaldos
Sector
Financial Services
Industry
Shell Companies
Address
5 West 21st Street New York City NY United States of America 10010
IPO Date
Oct 8, 2020
CIK
0001810560
Website
petraacquisition.com
Similar Companies
Deep Lake Capital Acquisition Corp. (DLCA)
Viveon Health Acquisition Corp. (VHAQ-UN)
Arowana Inc. - Ordinary Shares (ARWA)
Launch One Acquisition Corp. (LPAAW)
Cartesian Growth Corporation III (CGCT)
StoneBridge Acquisition II Corporation (APACU)
Business
Petra Acquisition, Inc. (PAICU) operates as a blank check company, or special purpose acquisition company (SPAC), with no significant ongoing operations and focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. Incorporated in 2019 and headquartered at 5 West 21st Street in New York, New York, the company targets opportunities primarily in the United States without specified industry or sector restrictions. In January 2022, Petra Acquisition completed a reverse merger transaction whereby it was acquired by Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapies such as REVTx-99 and REVDx-501, resulting in Petra being renamed Revelation Biosciences, Inc. and utilizing approximately $73 million in trust proceeds to fund clinical development.

Company News

Company News APIChatGPT

  • benzinga.com

    Respiratory Viral Infections-Focused Revelation Biosciences Turns To SPAC Deal For NASDAQ Debut

  • businesswire.com

    Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

  • globenewswire.com

    PETRA ACQUISITION, INC. ANNOUNCES SECURITIES TO COMMENCE SEPARATE TRADING

  • seekingalpha.com

    U.S. IPO Week Ahead: Chinese EV's Billion-Dollar Deal Closes Out Summer In A 2-IPO Week